Concert Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Summary

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) has announced its participation in two virtual investor conferences: the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, starting at 7:00 a.m. ET, and the Cantor Virtual Global Healthcare Conference on September 30, 2021, at 3:20 p.m. ET. Webcasts will be available on the company’s website for two weeks post-event. Concert is focused on developing small molecule drugs utilizing its DCE Platform® and is advancing a lead product candidate for alopecia areata.

LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate virtually at the following upcoming investor conferences:

• The H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, on-demand beginning at 7:00 a.m. ET; and
• The Cantor Virtual Global Healthcare Conference on September 30, 2021 at 3:20 p.m. ET.

Webcasts of the presentations may be accessed in the Investors section of the Company’s website at www.concertpharma.com. A replay of the conference webcasts will be available on Concert’s website for two weeks following the presentations.

About Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform^® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates. For more information please visit www.concertpharma.com or follow us on Twitter at @ConcertPharma or on LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210903005021/en/

Justine Koenigsberg

(781) 674-5284

ir@concertpharma.com

Source: Concert Pharmaceuticals, Inc.

FAQ

What conferences will Concert Pharmaceuticals participate in during September 2021?

Concert Pharmaceuticals will participate in the H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021, and the Cantor Virtual Global Healthcare Conference on September 30, 2021.

When will the H.C. Wainwright conference presentation be available for viewing?

The presentation at the H.C. Wainwright conference will be available on-demand starting at 7:00 a.m. ET on September 13, 2021.

How can I access the webcasts for Concert Pharmaceuticals' presentations?

Webcasts for the presentations can be accessed in the Investors section of Concert Pharmaceuticals' website.

What is the focus of Concert Pharmaceuticals' lead product candidate?

The lead product candidate of Concert Pharmaceuticals is in late-stage development for the treatment of alopecia areata.

How long will the conference webcasts remain available for replay?

The conference webcasts will be available for replay for two weeks following the presentations.